The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.V. Budzinskaya

Krasnov Research Institute of Eye Diseases

M.A. Afanasyeva

Research Institute of Eye Diseases

A.A. Plyukhova

Krasnov Research Institute of Eye Diseases

I.A. Novikov

Krasnov Research Institute of Eye Diseases

A.V. Shelankova

Research Institute of Eye Diseases

I.V. Andreeva

Research Institute of Eye Diseases

Effectiveness of anti-VEGF therapy for neovascular age-related macular degeneration in different types of exudative fluid localization

Authors:

M.V. Budzinskaya, M.A. Afanasyeva, A.A. Plyukhova, I.A. Novikov, A.V. Shelankova, I.V. Andreeva

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(6): 12‑17

Views: 710

Downloaded: 21


To cite this article:

Budzinskaya MV, Afanasyeva MA, Plyukhova AA, Novikov IA, Shelankova AV, Andreeva IV. Effectiveness of anti-VEGF therapy for neovascular age-related macular degeneration in different types of exudative fluid localization. Russian Annals of Ophthalmology. 2021;137(6):12‑17. (In Russ.)
https://doi.org/10.17116/oftalma202113706112

Recommended articles:
Diagnosis and clinical features of non-exudative macu­lar neovascularization. Russian Annals of Ophthalmology. 2023;(1):138-146
Modern achievements in the diagnosis and treatment of glaucoma. Russian Annals of Ophthalmology. 2023;(3):96-106
OCT classification of choroidal nevi. Russian Annals of Ophthalmology. 2023;(3):49-62
Age-related changes in human vitreous. Russian Annals of Ophthalmology. 2023;(3):106-111

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.